Topic

Washington

A collection of 516 issues

How to Get Gattex (Teduglutide) Approved by Aetna (CVS Health) in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Gattex (Teduglutide) Covered by Aetna (CVS Health) in Washington Aetna (CVS Health) requires prior authorization for Gattex (teduglutide) in short bowel syndrome patients dependent on parenteral nutrition ≥3 days/week for ≥12 months. Washington residents have strong appeal rights through the state's external review process

Lowering Out-of-Pocket Costs for Nourianz (Istradefylline) with Blue Cross Blue Shield in Washington: Copay Programs, Tiering Strategies & Appeals

Answer Box: Getting Nourianz Covered at the Lowest Cost Nourianz (istradefylline) is covered by Premera Blue Cross and Regence BlueShield in Washington as a specialty-tier drug, typically requiring prior authorization. Most commercially insured patients can reduce costs to $20-60/month using the Kyowa Kirin Cares copay program (up to $5,

How to Get Therakos CELLEX Photopheresis Covered by Cigna in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Therakos CELLEX Covered by Cigna in Washington Therakos CELLEX photopheresis requires prior authorization from Cigna's medical team (not Express Scripts) for FDA-approved conditions like CTCL or steroid-refractory GVHD. Submit via CoverMyMeds with specialist notes documenting failed standard therapies. If denied, Washington residents can appeal through

How to Get Xywav (Ca/Mg/K/Na oxybates) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization Guide

Answer Box: Getting Xywav Covered by Blue Cross Blue Shield in Washington Xywav (Ca/Mg/K/Na oxybates) requires prior authorization from Blue Cross Blue Shield plans in Washington, typically with step therapy requiring documented Xyrem failure. The fastest path: 1) Enroll in the XYWAV REMS program (same day), 2)

Work With Your Doctor to Get Ultomiris (Ravulizumab) Approved by Blue Cross Blue Shield in Washington: Provider Partnership Guide

Answer Box: Getting Ultomiris Covered in Washington To get Ultomiris (ravulizumab) approved by Blue Cross Blue Shield in Washington, you need prior authorization with specific clinical documentation for PNH, aHUS, myasthenia gravis, or NMOSD. Your doctor must submit lab results (flow cytometry for PNH, complement studies for aHUS), proof of

Getting Nucala (Mepolizumab) Covered by Humana in Washington: Complete Forms, Appeals & Support Guide

Answer Box: Fast Track to Nucala Coverage Nucala (mepolizumab) requires prior authorization for Humana Medicare Advantage plans in Washington. Submit the 2024 Request for Medicare Prescription Drug Coverage Determination Form with eosinophil counts ≥150 cells/μL and evidence of optimized inhaled therapy failure. Use CoverMyMeds for fastest processing (often under

How to Get Waylivra (Volanesorsen) Covered by Aetna CVS Health in Washington: Appeals Guide and Medical Necessity Process

Waylivra (volanesorsen) is not FDA-approved in the US and requires a medical necessity appeal through Aetna CVS Health rather than standard prior authorization. In Washington, you'll need genetic confirmation of familial chylomicronemia syndrome (FCS), documented failure of FDA-approved alternatives like Tryngolza, and a specialist letter detailing clinical rationale.

How to Get Tepezza (Teprotumumab) Covered by UnitedHealthcare in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tepezza Covered by UnitedHealthcare in Washington UnitedHealthcare requires prior authorization for Tepezza (teprotumumab-trbw, HCPCS J3241) under the medical benefit for moderate-to-severe thyroid eye disease (TED). Coverage criteria include Clinical Activity Score (CAS) ≥3, euthyroid status (TSH and free T3/T4 within 50% of normal), and documented corticosteroid

How to Get Cimzia (Certolizumab Pegol) Covered by Cigna in Washington: Complete PA Guide and Appeal Process

Answer Box: Getting Cimzia Covered by Cigna in Washington Cigna requires prior authorization for Cimzia (certolizumab pegol) across all FDA-approved conditions. In Washington, your fastest path to approval involves: (1) Having your specialist submit the PA form with documented failure of conventional therapy and preferred TNF inhibitors, plus required TB/

How to Get Vanflyta (Quizartinib) Covered by Cigna in Washington: Complete Prior Authorization & Appeals Guide

Answer Box: Getting Vanflyta (Quizartinib) Covered by Cigna in Washington Cigna requires prior authorization for Vanflyta (quizartinib) in FLT3-ITD-positive AML patients ≥18 years old with confirmed mutation via FDA-approved testing. Submit comprehensive documentation including baseline ECG showing QTc <450ms, REMS enrollment proof, and oncologist's medical necessity letter.